Malignant Neoplasm of Stomach Terminated Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Cancer, Gastric / Gastric Malignancies / Stomach Cancer / Gastric Cancers / Gastric Cancer / Gastric malignancy / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01774851A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and StomachTreatment
NCT02726399Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric CancerTreatment
NCT02005484A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease ProgressionTreatment